REQUEST A DEMO
Total
USD $0.00
Search more companies

Siflon Drugs And Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Siflon Drugs And Pharmaceuticals Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Siflon Drugs And Pharmaceuticals Private Limited is an unlisted company, incorporated on 30/01/2006. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24239TG2006PTC048931 and registration number is 048931.

Legal Address
Plat No:76&77,Manu Residency,Mythri Nagar Madinaguda,Miyapur
Hyderabad; Telangana; Postal Code: 500050

Contact Details: Purchase the Siflon Drugs And Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Siflon Drugs And Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Siflon Drugs And Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
January 30, 2006
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
30%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Siflon Drugs And Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-25.99%
Total operating revenue
-27.52%
Operating profit (EBIT)
-32.16%
EBITDA
-28.73%
Net Profit (Loss) for the Period
-33.59%
Total assets
15.94%
Total equity
30.24%
Operating Profit Margin (ROS)
-1.61%
Net Profit Margin
-1.51%
Return on Equity (ROE)
-22.31%
Debt to Equity Ratio
7.32%
Quick Ratio
-0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?